[Skip to Content]
[Skip to Content Landing]
Citations 0
Health Agencies Update
March 23/30, 2005

Drug Safety Monitoring

JAMA. 2005;293(12):1440. doi:10.1001/jama.293.12.1440-d

The Food and Drug Administration (FDA) has unveiled a new plan to improve drug safety monitoring, which includes the creation of an independent Drug Safety Oversight Board. Acting FDA Commissioner Lester M. Crawford, DVM, PhD, who was nominated last month by President Bush to assume the post permanently, announced the plan’s specific proposals, which will focus on making the FDA’s review and decision-making processes more independent and transparent (http://www.fda.gov/cder/drugsafety.htm).

First Page Preview View Large
First page PDF preview
First page PDF preview
×